• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Synergy Pharmaceuticals, Inc. (SGYP)

    -NasdaqGS
    2.91 Down 0.08(2.68%) Jan 30, 4:00PM EST
    |After Hours : 2.91 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:2.99
    Open:2.98
    Bid:2.40 x 200
    Ask:N/A
    1y Target Est:7.90
    Beta:2.35
    Next Earnings Date:N/A
    Day's Range:2.91 - 3.03
    52wk Range:2.45 - 6.70
    Volume:493,443
    Avg Vol (3m):764,886
    Market Cap:281.13M
    P/E (ttm):N/A
    EPS (ttm):-0.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGYP

    Comparison

    Symbol% ChgMkt Cap
    SGYPDown 2.68%281.13M
    IRWDDown 2.87%2.18B
    SLXPDown 0.35%8.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.98
    Quarterly EPS Est (Dec-14) :-0.28
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback